Abstract

BackgroundTick-borne infections have been increasing steadily over the years, with co-infections with Borrelia burgdorferi and Babesia microti/divergens emerging as a serious health problem. B. burgdorferi is a spirochetal bacterium that causes Lyme disease while protozoan pathogens belonging to Babesia species are responsible for babesiosis. Currently used serological tests do not always detect acute Lyme disease or babesiosis, and fail to differentiate cured patients from those who get re-infected. This is a major problem for proper diagnosis particularly in regions endemic for tick-borne diseases. Microscopy based evaluation of babesiosis is confirmatory but is labor intensive and insensitive such that many asymptomatic patients remain undetected and donate blood resulting in transfusion transmitted babesiosis.ResultsWe conducted multiplex qPCR for simultaneous diagnosis of active Lyme disease and babesiosis in 192 blood samples collected from a region endemic for both diseases. We document qPCR results obtained from testing of each sample three times to detect infection with each pathogen separately or together. Results for Lyme disease by qPCR were also compared with serological tests currently used for Lyme disease when available. Considering at least two out of three test results for consistency, 18.2% of patients tested positive for Lyme disease, 18.7% for co-infection with B. burgdorferi and B. microti and 6.3% showed only babesiosis.ConclusionsWith an 80% sensitivity for detection of Lyme disease, and ability to detect co-infection with B. microti, multiplex qPCR can be employed for diagnosis of these diseases to start appropriate treatment in a timely manner.

Highlights

  • Tick-borne infections have shown an alarming increase in the last decade

  • We conducted multiplex quantitative PCR (qPCR) for simultaneous diagnosis of active Lyme disease and babesiosis in 192 blood samples collected from a region endemic for both diseases

  • Results for Lyme disease by qPCR were compared with serological tests currently used for Lyme disease when available

Read more

Summary

Introduction

Tick-borne infections have shown an alarming increase in the last decade. According to the CDC, approximately 300,000 cases of Lyme disease and 2,000 cases of babesiosis occur in the United States per year [1, 2]. Diuk-Wasser summarized outcomes of several studies, which demonstrated that up to 40% of Lyme disease patients are infected with B. microti, and 2/3rd of babesiosis patients were infected with B. burgdorferi in the Northeastern USA [6] These results emphasize the importance of development and testing of a more efficient and high throughput assays to examine B. burgdorferi and B. microti simultaneously among patients in the endemic regions of North America and Europe. Used serological tests do not always detect acute Lyme disease or babesiosis, and fail to differentiate cured patients from those who get re-infected This is a major problem for proper diagnosis in regions endemic for tick-borne diseases. Microscopy based evaluation of babesiosis is confirmatory but is labor intensive and insensitive such that many asymptomatic patients remain undetected and donate blood resulting in transfusion transmitted babesiosis.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call